1. Home
  2. GAUZ vs FATE Comparison

GAUZ vs FATE Comparison

Compare GAUZ & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • FATE
  • Stock Information
  • Founded
  • GAUZ 2009
  • FATE 2007
  • Country
  • GAUZ Israel
  • FATE United States
  • Employees
  • GAUZ N/A
  • FATE N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAUZ Miscellaneous
  • FATE Health Care
  • Exchange
  • GAUZ Nasdaq
  • FATE Nasdaq
  • Market Cap
  • GAUZ 137.2M
  • FATE 130.7M
  • IPO Year
  • GAUZ 2024
  • FATE 2013
  • Fundamental
  • Price
  • GAUZ $6.42
  • FATE $1.07
  • Analyst Decision
  • GAUZ Strong Buy
  • FATE Hold
  • Analyst Count
  • GAUZ 3
  • FATE 7
  • Target Price
  • GAUZ $14.67
  • FATE $3.83
  • AVG Volume (30 Days)
  • GAUZ 564.9K
  • FATE 1.4M
  • Earning Date
  • GAUZ 08-13-2025
  • FATE 08-12-2025
  • Dividend Yield
  • GAUZ N/A
  • FATE N/A
  • EPS Growth
  • GAUZ N/A
  • FATE N/A
  • EPS
  • GAUZ N/A
  • FATE N/A
  • Revenue
  • GAUZ $101,165,000.00
  • FATE $13,335,000.00
  • Revenue This Year
  • GAUZ $28.49
  • FATE N/A
  • Revenue Next Year
  • GAUZ $47.77
  • FATE N/A
  • P/E Ratio
  • GAUZ N/A
  • FATE N/A
  • Revenue Growth
  • GAUZ 18.63
  • FATE 105.85
  • 52 Week Low
  • GAUZ $5.50
  • FATE $0.66
  • 52 Week High
  • GAUZ $13.00
  • FATE $5.49
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • FATE 40.63
  • Support Level
  • GAUZ N/A
  • FATE $1.19
  • Resistance Level
  • GAUZ N/A
  • FATE $1.35
  • Average True Range (ATR)
  • GAUZ 0.00
  • FATE 0.08
  • MACD
  • GAUZ 0.00
  • FATE -0.01
  • Stochastic Oscillator
  • GAUZ 0.00
  • FATE 3.45

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: